SERES THERAPEUTICS earnings per share and revenue

1S9 earnings per share for the last quarter are 0.49 CHF whereas the estimation was -0.07 CHF which accounts for 848.09% surprise. Company revenue for the same period amounts to 0.00 CHF despite the estimated figure of 26.27 M CHF. Estimated earnings per share for the next quarter are -0.17 CHF, and revenue is expected to reach 0.00 CHF. Also watch annual changes over time to get a bigger picture of 1S9 earnings per share and revenue dynamics.